Trials / Conditions / Gastric/Gastroesophageal Junction Cancer
Gastric/Gastroesophageal Junction Cancer
5 registered clinical trials studyying Gastric/Gastroesophageal Junction Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors NCT07358806 | Oscotec Inc. | Phase 1 |
| Not Yet Recruiting | A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors NCT07036185 | Shanghai Bao Pharmaceuticals Co., Ltd. | Phase 1 |
| Unknown | KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer NCT03847168 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Phase 1 |
| Completed | KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer NCT03925974 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Phase 2 |
| Completed | A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With U NCT03941873 | BeiGene | Phase 1 / Phase 2 |